News
ACTEMRA(R) (Tocilizumab) Significantly Reduces Rheumatoid Arthritis...
www.redorbit.com
We are encouraged that we will soon be able to offer this new treatment option and meaningful benefit to those who need it the most -- the RA patients," said Lars Birgerson, M.D., Ph.D., Vice President, Global Head Medical Affairs, Roche. About ACTEMRA (tocilizumab). ACTEMRA is the first humanized ...
(PRN) Xeloda(R) Plus Avastin(R) Combination May Produce Clinical...
www.chron.com
... combinations using cornerstone anticancer therapies such as Xeloda," said Lars Birgerson, MD, PhD, Vice President, Medical Affairs, Roche.
Adlai Nortye anuncia la contratación del Dr. Lars E. Birgerson
www.europapress.es
- Adlai Nortye anuncia la contratación del Dr. Lars E. Birgerson como director de desarrollo, presidente y...
Adlai Nortye Announces Engagement of Lars E. Birgerson, M.D., Ph.D.,...
247.libero.it
Prior to Adlai Nortye, Dr. Birgerson served as Senior Vice President, Medical R&D at Bristol-Myers Squibb , BMS, . At BMS, Dr. Birgerson was responsible for...
sorted by relevance / date